المؤلفون: Ehrens, Alexandra, Hoerauf, Achim, Hübner, Marc P.

المصدر: GMS Infectious Diseases, Vol 10, p Doc02 (2022)

مصطلحات موضوعية: filariae, onchocerciasis, wolbachia, doxycycline, abbv-4083, emodepside, oxfendazole, rifampicine, litomosoides sigmodontis, onchocerca volvulus, Infectious and parasitic diseases, RC109-216

وصف الملف: electronic resource

Relation: http://www.egms.de/static/en/journals/id/2022-10/id000079.shtml; https://doaj.org/toc/2195-8831

URL الوصول: https://doaj.org/article/bf47990c7ab240efa9f424accec0233e

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المصدر: GMS Infectious Diseases; VOL: 10; DOC02 /20220330/

مصطلحات الفهرس: filariae, onchocerciasis, Wolbachia, doxycycline, ABBV-4083, emodepside, oxfendazole, rifampicine, Litomosoides sigmodontis, Onchocerca volvulus, ddc: 610, article

URL: http://nbn-resolving.de/urn:nbn:de:0183-id0000798
http://www.egms.de/en/journals/id/2022-10/id000079.shtml
Alami NN, Carter DC, Kwatra NV, Zhao W, Snodgrass L, Porcalla AR, Klein CE, Cohen DE, Gallenberg LA, Carr RA, Marsh KC, Kempf DJ. Anti-Wolbachia Candidate ABBV-4083: Phase 1 Safety and Pharmacokinetics Clinical Trial in healthy Adults. 68th Annual Meeting of the American Society for Tropical Medicine and Hygiene; National Harbor, MD, USA; 2019 Nov 20-24. Abstract 1280.
Aljayyoussi G, Tyrer HE, Ford L, Sjoberg H, Pionnier N, Waterhouse D, Davies J, Gamble J, Metuge H, Cook DAN, Steven A, Sharma R, Guimaraes AF, Clare RH, Cassidy A, Johnston KL, Myhill L, Hayward L, Wanji S, Turner JD, Taylor MJ, Ward SA. Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis. Sci Rep. 2017 Mar;7(1):210. DOI: 10.1038/s41598-017-00322-5
An G, Murry DJ, Gajurel K, Bach T, Deye G, Stebounova LV, Codd EE, Horton J, Gonzalez AE, Garcia HH, Ince D, Hodgson-Zingman D, Nomicos EYH, Conrad T, Kennedy J, Jones W, Gilman RH, Winokur P. Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Volunteers: a Randomized, Placebo-Controlled First-in-Human Single-Dose Escalation Study. Antimicrob Agents Chemother. 2019 Apr;63(4):e02255-18. DOI: 10.1128/AAC.02255-18
Anderson J, Fuglsang H, de C Marshall TF. Effects of diethylcarbamazine on ocular onchocerciasis. Tropenmed Parasitol. 1976 Sep;27(3):263-78.
ISRCTN38954299 - The efficacy of rifampicin plus albendazole against river blindness (onchocerciasis) in Cameroon. ISRCTN registry. 2021 [last updated 2021 Dec 10]. Available from: https://www.isrctn.com/ISRCTN38954299
Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-4083 Capsules When Given Alone or In Combination With Albendazole Capsules Moves in The Body of Adult Participants With Onchocerca Volvulus Infection. NCT04913610. ClinicalTrials.gov. 2021 [last updated 2021 Jun 25]. Available from: https://clinicaltrials.gov/ct2/show/NCT04913610
Multiple Ascending Dose Study of Oxfendazole in Healthy Adult Volunteers. NCT03035760. ClinicalTrials.gov. 2017 [last updated 2019 Dec 17]. Available from: https://clinicaltrials.gov/ct2/show/NCT03035760
Development of AWZ1066S, a Small Molecule Anti-Wolbachia Candidate Macrofilaricide Drug (AWOL). NCT05084560. ClinicalTrials.gov. 2021 [last updated 2021 Oct 20]. Available from: https://clinicaltrials.gov/ct2/show/NCT05084560
Awadzi K, Opoku NO, Attah SK, Lazdins-Helds J, Kuesel AC. A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca volvulus infection. PLoS Negl Trop Dis. 2014 Jun;8(6):e2953. DOI: 10.1371/journal.pntd.0002953
Babu S, Nutman TB. Immunopathogenesis of lymphatic filarial disease. Semin Immunopathol. 2012 Nov;34(6):847-61. DOI: 10.1007/s00281-012-0346-4
Bach T, Galbiati S, Kennedy JK, Deye G, Nomicos EYH, Codd EE, Garcia HH, Horton J, Gilman RH, Gonzalez AE, Winokur P, An G. Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Adults in an Open-Label Phase 1 Multiple Ascending Dose and Food Effect Study. Antimicrob Agents Chemother. 2020 Oct 20;64(11):e01018-20. DOI: 10.1128/AAC.01018-20
Bah GS, Schneckener S, Hahnel SR, Bayang NH, Fieseler H, Schmuck GM, Krebber R, Sarr A, Terjung C, Ngangyung HF, Ekale DD, Mfopit YM, Rufener L, Graham-Brown J, Tanya VN, Glenschek-Sieberth M, Kulke D, Makepeace BL. Emodepside targets SLO-1 channels of Onchocerca ochengi and induces broad anthelmintic effects in a bovine model of onchocerciasis. PLoS Pathog. 2021 Jun 2;17(6):e1009601. DOI: 10.1371/journal.ppat.1009601
Bakowski MA, Shiroodi RK, Liu R, Olejniczak J, Yang B, Gagaring K, Guo H, White PM, Chappell L, Debec A, Landmann F, Dubben B, Lenz F, Struever D, Ehrens A, Frohberger SJ, Sjoberg H, Pionnier N, Murphy E, Archer J, Steven A, Chunda VC, Fombad FF, Chounna PW, Njouendou AJ, Metuge HM, Ndzeshang BL, Gandjui NV, Akumtoh DN, Kwenti TDB, Woods AK, Joseph SB, Hull MV, Xiong W, Kuhen KL, Taylor MJ, Wanji S, Turner JD, Hübner MP, Hoerauf A, Chatterjee AK, Roland J, Tremblay MS, Schultz PG, Sullivan W, Chu XJ, Petrassi HM, McNamara CW. Discovery of short-course antiwolbachial quinazolines for elimination of filarial worm infections. Sci Transl Med. 2019 May;11(491):eaav3523. DOI: 10.1126/scitranslmed.aav3523
Bandi C, McCall JW, Genchi C, Corona S, Venco L, Sacchi L. Effects of tetracycline on the filarial worms Brugia pahangi and Dirofilaria immitis and their bacterial endosymbionts Wolbachia. Int J Parasitol. 1999 Feb;29(2):357-64. DOI: 10.1016/s0020-7519(98)00200-8
Batsa Debrah L, Phillips RO, Pfarr K, Klarmann-Schulz U, Opoku VS, Nausch N, Owusu W, Mubarik Y, Sander AL, Lämmer C, Ritter M, Layland LE, Jacobsen M, Debrah AY, Hoerauf A. The Efficacy of Doxycycline Treatment on Infection: An Open-Label, Randomized Trial in Ghana. Am J Trop Med Hyg. 2019 Jul;101(1):84-92. DOI: 10.4269/ajtmh.18-0491
Belogurov GA, Vassylyeva MN, Sevostyanova A, Appleman JR, Xiang AX, Lira R, Webber SE, Klyuyev S, Nudler E, Artsimovitch I, Vassylyev DG. Transcription inactivation through local refolding of the RNA polymerase structure. Nature. 2009 Jan;457(7227):332-5. DOI: 10.1038/nature07510
Boeree MJ, Diacon AH, Dawson R, Narunsky K, du Bois J, Venter A, Phillips PP, Gillespie SH, McHugh TD, Hoelscher M, Heinrich N, Rehal S, van Soolingen D, van Ingen J, Magis-Escurra C, Burger D, Plemper van Balen G, Aarnoutse RE; PanACEA Consortium. A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis. Am J Respir Crit Care Med. 2015 May;191(9):1058-65. DOI: 10.1164/rccm.201407-1264OC
Boeree MJ, Heinrich N, Aarnoutse R, Diacon AH, Dawson R, Rehal S, Kibiki GS, Churchyard G, Sanne I, Ntinginya NE, Minja LT, Hunt RD, Charalambous S, Hanekom M, Semvua HH, Mpagama SG, Manyama C, Mtafya B, Reither K, Wallis RS, Venter A, Narunsky K, Mekota A, Henne S, Colbers A, van Balen GP, Gillespie SH, Phillips PPJ, Hoelscher M; PanACEA consortium. High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial. Lancet Infect Dis. 2017 Jan;17(1):39-49. DOI: 10.1016/S1473-3099(16)30274-2
Bulman CA, Bidlow CM, Lustigman S, Cho-Ngwa F, Williams D, Rascón AA Jr, Tricoche N, Samje M, Bell A, Suzuki B, Lim KC, Supakorndej N, Supakorndej P, Wolfe AR, Knudsen GM, Chen S, Wilson C, Ang KH, Arkin M, Gut J, Franklin C, Marcellino C, McKerrow JH, Debnath A, Sakanari JA. Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis. PLoS Negl Trop Dis. 2015 Feb;9(2):e0003534. DOI: 10.1371/journal.pntd.0003534
Büttner DW, Wanji S, Bazzocchi C, Bain O, Fischer P. Obligatory symbiotic Wolbachia endobacteria are absent from Loa loa. Filaria J. 2003 May;2(1):10. DOI: 10.1186/1475-2883-2-10
Capparelli EV, Bricker-Ford R, Rogers MJ, McKerrow JH, Reed SL. Phase I Clinical Trial Results of Auranofin, a Novel Antiparasitic Agent. Antimicrob Agents Chemother. 2016 Dec 27;61(1):e01947-16. DOI: 10.1128/AAC.01947-16
Casiraghi M, Favia G, Cancrini G, Bartoloni A, Bandi C. Molecular identification of Wolbachia from the filarial nematode Mansonella ozzardi. Parasitol Res. 2001 May;87(5):417-20. DOI: 10.1007/s004360000368
CDC. Parasites - Onchocerciasis (also known as River Blindness). [last updated 2021 Nov 10]. Available from: https://www.cdc.gov/parasites/onchocerciasis/health_professionals/index.html
CDC. Parasites - Cysticercosis: Resources for Health Professionals. [last reviewed 2020 Oct 22]. Available from: https://www.cdc.gov/parasites/cysticercosis/health_professionals/index.html
Clare RH, Bardelle C, Harper P, Hong WD, Börjesson U, Johnston KL, Collier M, Myhill L, Cassidy A, Plant D, Plant H, Clark R, Cook DAN, Steven A, Archer J, McGillan P, Charoensutthivarakul S, Bibby J, Sharma R, Nixon GL, Slatko BE, Cantin L, Wu B, Turner J, Ford L, Rich K, Wigglesworth M, Berry NG, O'Neill PM, Taylor MJ, Ward SA. Industrial scale high-throughput screening delivers multiple fast acting macrofilaricides. Nat Commun. 2019 Jan;10(1):11. DOI: 10.1038/s41467-018-07826-2
Codd EE, Ng HH, McFarlane C, Riccio ES, Doppalapudi R, Mirsalis JC, Horton RJ, Gonzalez AE, Garcia HH, Gilman RH; Cysticercosis Working Group in Peru. Preclinical studies on the pharmacokinetics, safety, and toxicology of oxfendazole: toward first in human studies. Int J Toxicol. 2015 Mar-Apr;34(2):129-37. DOI: 10.1177/1091581815569582
Coulibaly YI, Dembele B, Diallo AA, Lipner EM, Doumbia SS, Coulibaly SY, Konate S, Diallo DA, Yalcouye D, Kubofcik J, Doumbo OK, Traore AK, Keita AD, Fay MP, Traore SF, Nutman TB, Klion AD. A randomized trial of doxycycline for Mansonella perstans infection. N Engl J Med. 2009 Oct;361(15):1448-58. DOI: 10.1056/NEJMoa0900863
Dadzie KY, Remme J, Rolland A, Thylefors B. Ocular onchocerciasis and intensity of infection in the community. II. West African rainforest foci of the vector Simulium yahense. Trop Med Parasitol. 1989 Sep;40(3):348-54.
Debrah AY, Mand S, Marfo-Debrekyei Y, Batsa L, Pfarr K, Buttner M, Adjei O, Buttner D, Hoerauf A. Macrofilaricidal effect of 4 weeks of treatment with doxycycline on Wuchereria bancrofti. Trop Med Int Health. 2007 Dec;12(12):1433-41. DOI: 10.1111/j.1365-3156.2007.01949.x
Debrah AY, Mand S, Specht S, Marfo-Debrekyei Y, Batsa L, Pfarr K, Larbi J, Lawson B, Taylor M, Adjei O, Hoerauf A. Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis. PLoS Pathog. 2006 Sep;2(9):e92. DOI: 10.1371/journal.ppat.0020092
Debrah AY, Mand S, Marfo-Debrekyei Y, Larbi J, Adjei O, Hoerauf A. Assessment of microfilarial loads in the skin of onchocerciasis patients after treatment with different regimens of doxycycline plus ivermectin. Filaria J. 2006 Feb;5:1. DOI: 10.1186/1475-2883-5-1
DNDi. R&D Portfolio Update February 2019: DNDi Filarial diseases programme. 2019 Feb 21. Available from: https://dndi.org/news/2019/filaria-rnd-status-2019
Drugs for Neglected Diseases Initiative (DNDi). Filaria: river blindness - Tylamac (ABBV-4083). 2015 [last updated 2022 Mar 1]. Available from: https://www.dndi.org/diseases-projects/portfolio/abbv-4083
Drugs for Neglected Diseases Initiative (DNDi). Filaria: river blindness - CC6166. 2016 [last updated 2021 Jun 1]. Available from: https://dndi.org/research-development/portfolio/cc6166
Dunn C, Callahan K, Katabarwa M, Richards F, Hopkins D, Withers PC Jr, Buyon LE, McFarland D. The Contributions of Onchocerciasis Control and Elimination Programs toward the Achievement of the Millennium Development Goals. PLoS Negl Trop Dis. 2015 May;9(5):e0003703. DOI: 10.1371/journal.pntd.0003703
Ehrens A, Lunde CS, Jacobs RT, Struever D, Koschel M, Frohberger SJ, Lenz F, Fendler M, Turner JD, Ward SA, Taylor MJ, Freund YR, Stefanakis R, Easom E, Li X, Plattner JJ, Hoerauf A, Hübner MP. In vivo efficacy of the boron-pleuromutilin AN11251 against Wolbachia of the rodent filarial nematode Litomosoides sigmodontis. PLoS Negl Trop Dis. 2020 Jan;14(1):e0007957. DOI: 10.1371/journal.pntd.0007957
Ette EI, Thomas WO, Achumba JI. Ivermectin: a long-acting microfilaricidal agent. DICP. 1990 Apr;24(4):426-33. DOI: 10.1177/106002809002400417
Finkelstein AE, Walz DT, Batista V, Mizraji M, Roisman F, Misher A. Auranofin. New oral gold compound for treatment of rheumatoid arthritis. Ann Rheum Dis. 1976;35(3):251-7.
Fischer P, Wibowo H, Pischke S, Rückert P, Liebau E, Ismid IS, Supali T. PCR-based detection and identification of the filarial parasite Brugia timori from Alor Island, Indonesia. Ann Trop Med Parasitol. 2002 Dec;96(8):809-21. DOI: 10.1179/000349802125002239
Foster J, Ganatra M, Kamal I, Ware J, Makarova K, Ivanova N, Bhattacharyya A, Kapatral V, Kumar S, Posfai J, Vincze T, Ingram J, Moran L, Lapidus A, Omelchenko M, Kyrpides N, Ghedin E, Wang S, Goltsman E, Joukov V, Ostrovskaya O, Tsukerman K, Mazur M, Comb D, Koonin E, Slatko B. The Wolbachia genome of Brugia malayi: endosymbiont evolution within a human pathogenic nematode. PLoS Biol. 2005 Apr;3(4):e121. DOI: 10.1371/journal.pbio.0030121
Francis H, Awadzi K, Ottesen EA. The Mazzotti reaction following treatment of onchocerciasis with diethylcarbamazine: clinical severity as a function of infection intensity. Am J Trop Med Hyg. 1985 May;34(3):529-36. DOI: 10.4269/ajtmh.1985.34.529
García HH, Evans CA, Nash TE, Takayanagui OM, White AC Jr, Botero D, Rajshekhar V, Tsang VC, Schantz PM, Allan JC, Flisser A, Correa D, Sarti E, Friedland JS, Martinez SM, Gonzalez AE, Gilman RH, Del Brutto OH. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev. 2002 Oct;15(4):747-56. DOI: 10.1128/CMR.15.4.747-756.2002
Gardon J, Gardon-Wendel N, Demanga N, Kamgno J, Chippaux JP, Boussinesq M. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet. 1997;350(9070):18-22.
Geary TG, Mackenzie CD. Progress and challenges in the discovery of macrofilaricidal drugs. Expert Rev Anti Infect Ther. 2011 Aug;9(8):681-95. DOI: 10.1586/eri.11.76
Ghedin E, Wang S, Spiro D, Caler E, Zhao Q, Crabtree J, Allen JE, Delcher AL, Guiliano DB, Miranda-Saavedra D, Angiuoli SV, Creasy T, Amedeo P, Haas B, El-Sayed NM, Wortman JR, Feldblyum T, Tallon L, Schatz M, Shumway M, Koo H, Salzberg SL, Schobel S, Pertea M, Pop M, White O, Barton GJ, Carlow CK, Crawford MJ, Daub J, Dimmic MW, Estes CF, Foster JM, Ganatra M, Gregory WF, Johnson NM, Jin J, Komuniecki R, Korf I, Kumar S, Laney S, Li BW, Li W, Lindblom TH, Lustigman S, Ma D, Maina CV, Martin DM, McCarter JP, McReynolds L, Mitreva M, Nutman TB, Parkinson J, Peregrín-Alvarez JM, Poole C, Ren Q, Saunders L, Sluder AE, Smith K, Stanke M, Unnasch TR, Ware J, Wei AD, Weil G, Williams DJ, Zhang Y, Williams SA, Fraser-Liggett C, Slatko B, Blaxter ML, Scott AL. Draft genome of the filarial nematode parasite Brugia malayi. Science. 2007 Sep;317(5845):1756-60. DOI: 10.1126/science.1145406
Ghedin E, Wang S, Foster JM, Slatko BE. First sequenced genome of a parasitic nematode. Trends Parasitol. 2004 Apr;20(4):151-3. DOI: 10.1016/j.pt.2004.01.011
Gonzalez AE, Bustos JA, Jimenez JA, Rodriguez ML, Ramirez MG, Gilman RH, Garcia HH; Cysticercosis Working Group in Peru. Efficacy of diverse antiparasitic treatments for cysticercosis in the pig model. Am J Trop Med Hyg. 2012 Aug;87(2):292-6. DOI: 10.4269/ajtmh.2012.11-0371
Grandi G, Morchon R, Kramer L, Kartashev V, Simon F. Wolbachia in Dirofilaria repens, an agent causing human subcutaneous dirofilariasis. J Parasitol. 2008 Dec;94(6):1421-3. DOI: 10.1645/GE-1575.1
Grüneberg RN, Emmerson AM, Cremer AW. Rifampicin for non-tuberculous infections? Chemotherapy. 1985;31(4):324-8. DOI: 10.1159/000238355
Haselow NJ, Akame J, Evini C, Akongo S. Programmatic and Communication Issues in Relation to Serious Adverse Events Following Ivermectin Treatment in areas Co-endemic for Onchocerciasis and Loiasis. Filaria J. 2003 Oct;2 Suppl 1:S10. DOI: 10.1186/1475-2883-2-S1-S10
Helminth Elimination Platform (HELP). Developing new drugs for infections caused by parasitic worms. [last accessed 2022 Mar 22]. Available from: https://eliminateworms.org
Helminth Elimination Platform (HELP). River blindness (Onchocerciasis). [last accessed 2022 Mar 22]. Available from: https://eliminateworms.org/diseases/river-blindness
Henkle-Dührsen K, Eckelt VH, Wildenburg G, Blaxter M, Walter RD. Gene structure, activity and localization of a catalase from intracellular bacteria in Onchocerca volvulus. Mol Biochem Parasitol. 1998 Oct;96(1-2):69-81. DOI: 10.1016/s0166-6851(98)00109-1
Hoerauf A, Volkmann L, Nissen-Paehle K, Schmetz C, Autenrieth I, Büttner DW, Fleischer B. Targeting of Wolbachia endobacteria in Litomosoides sigmodontis: comparison of tetracyclines with chloramphenicol, macrolides and ciprofloxacin. Trop Med Int Health. 2000 Apr;5(4):275-9.
Hoerauf A. Onchocerciasis. In: Guerrant RL, Walker DH, Weller PF, editors. Tropical Infectious Diseases: Principles, Pathogens and Practice. Edinburgh: Elsevier; 2011. p. 741-9.
Hoerauf A, Mand S, Volkmann L, Büttner M, Marfo-Debrekyei Y, Taylor M, Adjei O, Büttner DW. Doxycycline in the treatment of human onchocerciasis: Kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms. Microbes Infect. 2003 Apr;5(4):261-73. DOI: 10.1016/s1286-4579(03)00026-1
Hoerauf A, Mand S, Fischer K, Kruppa T, Marfo-Debrekyei Y, Debrah AY, Pfarr KM, Adjei O, Büttner DW. Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production. Med Microbiol Immunol. 2003 Nov;192(4):211-6. DOI: 10.1007/s00430-002-0174-6
Hoerauf A, Volkmann L, Hamelmann C, Adjei O, Autenrieth IB, Fleischer B, Büttner DW. Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis. Lancet. 2000 Apr;355(9211):1242-3. DOI: 10.1016/S0140-6736(00)02095-X
Hoerauf A, Specht S, Büttner M, Pfarr K, Mand S, Fimmers R, Marfo-Debrekyei Y, Konadu P, Debrah AY, Bandi C, Brattig N, Albers A, Larbi J, Batsa L, Taylor MJ, Adjei O, Büttner DW. Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study. Med Microbiol Immunol. 2008 Sep;197(3):335. DOI: 10.1007/s00430-007-0072-z
Hoerauf A. Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis. Curr Opin Infect Dis. 2008 Dec;21(6):673-81. DOI: 10.1097/QCO.0b013e328315cde7
Hoerauf A, Nissen-Pähle K, Schmetz C, Henkle-Dührsen K, Blaxter ML, Büttner DW, Gallin MY, Al-Qaoud KM, Lucius R, Fleischer B. Tetracycline therapy targets intracellular bacteria in the filarial nematode Litomosoides sigmodontis and results in filarial infertility. J Clin Invest. 1999 Jan;103(1):11-8. DOI: 10.1172/JCI4768
Hoerauf A, Mand S, Adjei O, Fleischer B, Büttner DW. Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment. Lancet. 2001 May;357(9266):1415-6. DOI: 10.1016/S0140-6736(00)04581-5
Hoerauf A, Specht S, Marfo-Debrekyei Y, Büttner M, Debrah AY, Mand S, Batsa L, Brattig N, Konadu P, Bandi C, Fimmers R, Adjei O, Büttner DW. Efficacy of 5-week doxycycline treatment on adult Onchocerca volvulus. Parasitol Res. 2009 Jan;104(2):437-47. DOI: 10.1007/s00436-008-1217-8
Hong WD, Benayoud F, Nixon GL, Ford L, Johnston KL, Clare RH, Cassidy A, Cook DAN, Siu A, Shiotani M, Webborn PJH, Kavanagh S, Aljayyoussi G, Murphy E, Steven A, Archer J, Struever D, Frohberger SJ, Ehrens A, Hübner MP, Hoerauf A, Roberts AP, Hubbard ATM, Tate EW, Serwa RA, Leung SC, Qie L, Berry NG, Gusovsky F, Hemingway J, Turner JD, Taylor MJ, Ward SA, O'Neill PM. AWZ1066S, a highly specific anti-Wolbachia drug candidate for a short-course treatment of filariasis. Proc Natl Acad Sci U S A. 2019 Jan;116(4):1414-9. DOI: 10.1073/pnas.1816585116
Horton J. Albendazole: a review of anthelmintic efficacy and safety in humans. Parasitology. 2000;121 Suppl:S113-32. DOI: 10.1017/s0031182000007290
Hübner MP, Von Geldern TW, Marsh K, Specht S, Koschel M, Ehrens A, Frohberger SJ, Gunderson E, Bulman C, Lim KC , Taylor MJ, Turner JD, Ward SA, Sakanari J, Kempf D, Hoerauf A. Preclincial efficacy of the novel macrofilaricidal drug candidate ABBV-4083. 68th Annual Meeting of the American Society for Tropical Medicine and Hygiene; National Harbor, MD, USA; 2019 Nov 20-24. Abstract 1281.
Hübner MP, Townson S, Gokool S, Tagboto S, Maclean MJ, Verocai GG, Wolstenholme AJ, Frohberger SJ, Hoerauf A, Specht S, Scandale I, Harder A, Glenschek-Sieberth M, Hahnel SR, Kulke D. Evaluation of the in vitro susceptibility of various filarial nematodes to emodepside. Int J Parasitol Drugs Drug Resist. 2021 Dec;17:27-35. DOI: 10.1016/j.ijpddr.2021.07.005
Hübner MP, Hoerauf A, Townson S, Gokool S, Martin C, Chojnowsk A, Kreiss T, Prorok M, Siekierka J, Zeldis J, Canan S, Khetani V, Scandal I, Hawryluk NA. Identification of new Macrofilaricidal Compounds for Treatment of Onchocerciasis. 66th Annual Meeting of the American Society for Tropical Medicine and Hygiene; Baltimore, Maryland, USA; 2017 Nov 5-9.
Hübner MP, Ehrens A, Koschel M, Dubben B, Lenz F, Frohberger SJ, Specht S, Quirynen L, Lachau-Durand S, Tekle F, Baeten B, Engelen M, Mackenzie CD, Hoerauf A. Macrofilaricidal efficacy of single and repeated oral and subcutaneous doses of flubendazole in Litomosoides sigmodontis infected jirds. PLoS Negl Trop Dis. 2019 Jan;13(1):e0006320. DOI: 10.1371/journal.pntd.0006320
Hübner MP, Hoerauf A, Blömker D, Townson S, Gokool S, Martin C, Vallarino-Lhermitte N, Chojnowski A, Kreiss T, Prorok M, Siekierka J, Khetani V, Camardo J, Canan S, Scandale I, Hawryluk N. Identification of potential clinical candidates with macrofilaricidal efficacy for the treatment of onchocerciasis. 66th Annual Meeting of the American Society for Tropical Medicine and Hygiene; Baltimore, Maryland, USA; 2017 Nov 5-9.
Hübner MP, Koschel M, Struever D, Nikolov V, Frohberger SJ, Ehrens A, Fendler M, Johannes I, von Geldern TW, Marsh K, Turner JD, Taylor MJ, Ward SA, Pfarr K, Kempf DJ, Hoerauf A. In vivo kinetics of Wolbachia depletion by ABBV-4083 in L. sigmodontis adult worms and microfilariae. PLoS Negl Trop Dis. 2019 Aug 5;13(8):e0007636. DOI: 10.1371/journal.pntd.0007636
Hübner MP, Martin C, Specht S, Koschel M, Dubben B, Frohberger SJ, Ehrens A, Fendler M, Struever D, Mitre E, Vallarino-Lhermitte N, Gokool S, Lustigman S, Schneider M, Townson S, Hoerauf A, Scandale I. Oxfendazole mediates macrofilaricidal efficacy against the filarial nematode Litomosoides sigmodontis in vivo and inhibits Onchocerca spec. motility in vitro. PLoS Negl Trop Dis. 2020 Jul;14(7):e0008427. DOI: 10.1371/journal.pntd.0008427
Irschik H, Jansen R, Höfle G, Gerth K, Reichenbach H. The corallopyronins, new inhibitors of bacterial RNA synthesis from Myxobacteria. J Antibiot (Tokyo). 1985 Feb;38(2):145-52. DOI: 10.7164/antibiotics.38.145
Irvine MA, Stolk WA, Smith ME, Subramanian S, Singh BK, Weil GJ, Michael E, Hollingsworth TD. Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study. Lancet Infect Dis. 2017 Apr;17(4):451-8. DOI: 10.1016/S1473-3099(16)30467-4
Jacobs RT, Lunde CS, Freund YR, Hernandez V, Li X, Xia Y, Carter DS, Berry PW, Halladay J, Rock F, Stefanakis R, Easom E, Plattner JJ, Ford L, Johnston KL, Cook DAN, Clare R, Cassidy A, Myhill L, Tyrer H, Gamble J, Guimaraes AF, Steven A, Lenz F, Ehrens A, Frohberger SJ, Koschel M, Hoerauf A, Hübner MP, McNamara CW, Bakowski MA, Turner JD, Taylor MJ, Ward SA. Boron-Pleuromutilins as Anti-Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic Filariasis. J Med Chem. 2019 Mar;62(5):2521-40. DOI: 10.1021/acs.jmedchem.8b01854
Katz WA, Alexander S, Bland JH, Blechman W, Bluhm GB, Bonebrake RA, Falbo A, Greenwald RA, Hartman S, Hobbs T, Indenbaum S, Lergier JE, Lanier BG, Lightfoot RW Jr, Phelps P, Sheon RP, Torretti D, Wenger ME, Wilske K. The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis. J Rheumatol Suppl. 1982 Jul-Aug;8:173-8.
King CL, Suamani J, Sanuku N, Cheng YC, Satofan S, Mancuso B, Goss CW, Robinson LJ, Siba PM, Weil GJ, Kazura JW. A Trial of a Triple-Drug Treatment for Lymphatic Filariasis. N Engl J Med. 2018 Nov;379(19):1801-10. DOI: 10.1056/NEJMoa1706854
Kozek WJ, Marroquin HF. Intracytoplasmic bacteria in Onchocerca volvulus. Am J Trop Med Hyg. 1977 Jul;26(4):663-78. DOI: 10.4269/ajtmh.1977.26.663
Krücken J, Holden-Dye L, Keiser J, Prichard RK, Townson S, Makepeace BL, Hübner MP, Hahnel SR, Scandale I, Harder A, Kulke D. Development of emodepside as a possible adulticidal treatment for human onchocerciasis - The fruit of a successful industrial-academic collaboration. PLoS Pathog. 2021 Jul;17(7):e1009682. DOI: 10.1371/journal.ppat.1009682
Krücken J, Harder A, Jeschke P, Holden-Dye L, O'Connor V, Welz C, von Samson-Himmelstjerna G. Anthelmintic cyclcooctadepsipeptides: complex in structure and mode of action. Trends Parasitol. 2012 Sep;28(9):385-94. DOI: 10.1016/j.pt.2012.06.005
Kulke D, von Samson-Himmelstjerna G, Miltsch SM, Wolstenholme AJ, Jex AR, Gasser RB, Ballesteros C, Geary TG, Keiser J, Townson S, Harder A, Krücken J. Characterization of the Ca2+-gated and voltage-dependent K+-channel Slo-1 of nematodes and its interaction with emodepside. PLoS Negl Trop Dis. 2014 Dec;8(12):e3401. DOI: 10.1371/journal.pntd.0003401
Kwarteng A, Ahuno ST, Akoto FO. Killing filarial nematode parasites: role of treatment options and host immune response. Infect Dis Poverty. 2016 Oct;5(1):86. DOI: 10.1186/s40249-016-0183-0
Lachau-Durand S, Lammens L, van der Leede BJ, Van Gompel J, Bailey G, Engelen M, Lampo A. Preclinical toxicity and pharmacokinetics of a new orally bioavailable flubendazole formulation and the impact for clinical trials and risk/benefit to patients. PLoS Negl Trop Dis. 2019 Jan;13(1):e0007026. DOI: 10.1371/journal.pntd.0007026
Langworthy NG, Renz A, Mackenstedt U, Henkle-Dührsen K, de Bronsvoort MB, Tanya VN, Donnelly MJ, Trees AJ. Macrofilaricidal activity of tetracycline against the filarial nematode Onchocerca ochengi: elimination of Wolbachia precedes worm death and suggests a dependent relationship. Proc Biol Sci. 2000 Jun;267(1448):1063-9. DOI: 10.1098/rspb.2000.1110
Li Z, Carlow CK. Characterization of transcription factors that regulate the type IV secretion system and riboflavin biosynthesis in Wolbachia of Brugia malayi. PLoS One. 2012;7(12):e51597. DOI: 10.1371/journal.pone.0051597
Macfarlane CL, Budhathoki SS, Johnson S, Richardson M, Garner P. Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis. Cochrane Database Syst Rev. 2019 Jan;1:CD003753. DOI: 10.1002/14651858.CD003753.pub4
Mand S, Debrah AY, Klarmann U, Batsa L, Marfo-Debrekyei Y, Kwarteng A, Specht S, Belda-Domene A, Fimmers R, Taylor M, Adjei O, Hoerauf A. Doxycycline improves filarial lymphedema independent of active filarial infection: a randomized controlled trial. Clin Infect Dis. 2012 Sep;55(5):621-30. DOI: 10.1093/cid/cis486
Milton P, Hamley JID, Walker M, Basáñez MG. Moxidectin: an oral treatment for human onchocerciasis. Expert Rev Anti Infect Ther. 2020 Nov;18(11):1067-81. DOI: 10.1080/14787210.2020.1792772
Morgan DW. Toxicity study of oxfendazole in pregnant sows. Vet Rec. 1982 Aug;111(8):161-3. DOI: 10.1136/vr.111.8.161
Mukhopadhyay J, Das K, Ismail S, Koppstein D, Jang M, Hudson B, Sarafianos S, Tuske S, Patel J, Jansen R, Irschik H, Arnold E, Ebright RH. The RNA polymerase "switch region" is a target for inhibitors. Cell. 2008 Oct;135(2):295-307. DOI: 10.1016/j.cell.2008.09.033
Opoku NO, Bakajika DK, Kanza EM, Howard H, Mambandu GL, Nyathirombo A, Nigo MM, Kasonia K, Masembe SL, Mumbere M, Kataliko K, Larbelee JP, Kpawor M, Bolay KM, Bolay F, Asare S, Attah SK, Olipoh G, Vaillant M, Halleux CM, Kuesel AC. Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial. Lancet. 2018 Oct;392(10154):1207-16. DOI: 10.1016/S0140-6736(17)32844-1
Pion SD, Filipe JA, Kamgno J, Gardon J, Basáñez MG, Boussinesq M. Microfilarial distribution of Loa loa in the human host: population dynamics and epidemiological implications. Parasitology. 2006 Jul;133(Pt 1):101-9. DOI: 10.1017/S0031182006000035
Pionnier NP, Sjoberg H, Chunda VC, Fombad FF, Chounna PW, Njouendou AJ, Metuge HM, Ndzeshang BL, Gandjui NV, Akumtoh DN, Tayong DB, Taylor MJ, Wanji S, Turner JD. Mouse models of Loa loa. Nat Commun. 2019 Mar;10(1):1429. DOI: 10.1038/s41467-019-09442-0
Reddy AB, Rao UR, Chandrashekar R, Shrivastava R, Subrahmanyam D. Comparative efficacy of some benzimidazoles and amoscanate (Go.9333) against experimental filarial infections. Tropenmed Parasitol. 1983 Dec;34(4):259-62.
Rentsch A, Kalesse M. The total synthesis of corallopyronin A and myxopyronin B. Angew Chem Int Ed Engl. 2012 Nov 5;51(45):11381-4. DOI: 10.1002/anie.201206560
Russell GJ, Gill JH, Lacey E. Binding of [3H]benzimidazole carbamates to mammalian brain tubulin and the mechanism of selective toxicity of the benzimidazole anthelmintics. Biochem Pharmacol. 1992;43(5):1095-100.
Schäberle TF, Schmitz A, Zocher G, Schiefer A, Kehraus S, Neu E, Roth M, Vassylyev DG, Stehle T, Bierbaum G, Hoerauf A, Pfarr K, König GM. Insights into Structure-Activity Relationships of Bacterial RNA Polymerase Inhibiting Corallopyronin Derivatives. J Nat Prod. 2015 Oct;78(10):2505-9. DOI: 10.1021/acs.jnatprod.5b00175
Schiefer A, Hübner MP, Krome A, Lämmer C, Ehrens A, Aden T, Koschel M, Neufeld H, Chaverra-Muñoz L, Jansen R, Kehraus S, König GM, Pogorevc D, Müller R, Stadler M, Hüttel S, Hesterkamp T, Wagner K, Pfarr K, Hoerauf A. Corallopyronin A for short-course anti-wolbachial, macrofilaricidal treatment of filarial infections. PLoS Negl Trop Dis. 2020 Dec;14(12):e0008930. DOI: 10.1371/journal.pntd.0008930
Schiefer A, Schmitz A, Schäberle TF, Specht S, Lämmer C, Johnston KL, Vassylyev DG, König GM, Hoerauf A, Pfarr K. Corallopyronin A specifically targets and depletes essential obligate Wolbachia endobacteria from filarial nematodes in vivo. J Infect Dis. 2012 Jul;206(2):249-57. DOI: 10.1093/infdis/jis341
Serrano-Parreño B, Carretón E, Caro-Vadillo A, Falcón-Cordón S, Falcón-Cordón Y, Montoya-Alonso JA. Pulmonary hypertension in dogs with heartworm before and after the adulticide protocol recommended by the American Heartworm Society. Vet Parasitol. 2017 Mar;236:34-7. DOI: 10.1016/j.vetpar.2017.02.001
Simonsen PE. Filariases. In: Cook G, Zumla A, editors. Manson's tropical diseases. London: Elsevier; 2009. p. 1477-513.
Sironi M, Bandi C, Sacchi L, Di Sacco B, Damiani G, Genchi C. Molecular evidence for a close relative of the arthropod endosymbiont Wolbachia in a filarial worm. Mol Biochem Parasitol. 1995;74(2):223-7.
Song L, Li J, Xie S, Qian C, Wang J, Zhang W, Yin X, Hua Z, Yu C. Thioredoxin glutathione reductase as a novel drug target: evidence from Schistosoma japonicum. PLoS One. 2012;7(2):e31456. DOI: 10.1371/journal.pone.0031456
Specht S, Hoerauf A, Adjei O, Debrah A, Büttner DW. Newly acquired Onchocerca volvulus filariae after doxycycline treatment. Parasitol Res. 2009 Dec;106(1):23-31. DOI: 10.1007/s00436-009-1624-5
Specht S, Mand S, Marfo-Debrekyei Y, Debrah AY, Konadu P, Adjei O, Büttner DW, Hoerauf A. Efficacy of 2- and 4-week rifampicin treatment on the Wolbachia of Onchocerca volvulus. Parasitol Res. 2008 Nov;103(6):1303-9. DOI: 10.1007/s00436-008-1133-y
Strübing U, Lucius R, Hoerauf A, Pfarr KM. Mitochondrial genes for heme-dependent respiratory chain complexes are up-regulated after depletion of Wolbachia from filarial nematodes. Int J Parasitol. 2010 Aug;40(10):1193-202. DOI: 10.1016/j.ijpara.2010.03.004
Surin J, Denham DA. Comparative susceptibility to anthelmintics of Brugia pahangi in jirds infected by different methods. J Helminthol. 1990 Sep;64(3):232-8. DOI: 10.1017/s0022149x00012219
Tamarozzi F, Halliday A, Gentil K, Hoerauf A, Pearlman E, Taylor MJ. Onchocerciasis: the role of Wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis, and treatment. Clin Microbiol Rev. 2011 Jul;24(3):459-68. DOI: 10.1128/CMR.00057-10
Taylor MJ, Awadzi K, Basáñez MG, Biritwum N, Boakye D, Boatin B, Bockarie M, Churcher TS, Debrah A, Edwards G, Hoerauf A, Mand S, Matthews G, Osei-Atweneboana M, Prichard RK, Wanji S, Adjei O. Onchocerciasis Control: Vision for the Future from a Ghanian perspective. Parasit Vectors. 2009 Jan;2(1):7. DOI: 10.1186/1756-3305-2-7
Taylor MJ, Bilo K, Cross HF, Archer JP, Underwood AP. 16S rDNA phylogeny and ultrastructural characterization of Wolbachia intracellular bacteria of the filarial nematodes Brugia malayi, B. pahangi, and Wuchereria bancrofti. Exp Parasitol. 1999 Apr;91(4):356-61. DOI: 10.1006/expr.1998.4383
Taylor MJ, Bandi C, Hoerauf A. Wolbachia bacterial endosymbionts of filarial nematodes. Adv Parasitol. 2005;60:245-84. DOI: 10.1016/S0065-308X(05)60004-8
Taylor MJ, Hoerauf A, Bockarie M. Lymphatic filariasis and onchocerciasis. Lancet. 2010 Oct;376(9747):1175-85. DOI: 10.1016/S0140-6736(10)60586-7
Taylor MJ, von Geldern TW, Ford L, Hübner MP, Marsh K, Johnston KL, Sjoberg HT, Specht S, Pionnier N, Tyrer HE, Clare RH, Cook DAN, Murphy E, Steven A, Archer J, Bloemker D, Lenz F, Koschel M, Ehrens A, Metuge HM, Chunda VC, Ndongmo Chounna PW, Njouendou AJ, Fombad FF, Carr R, Morton HE, Aljayyoussi G, Hoerauf A, Wanji S, Kempf DJ, Turner JD, Ward SA. Preclinical development of an oral anti-macrolide drug for the treatment of lymphatic filariasis and onchocerciasis. Sci Transl Med. 2019 Mar;11(483):eaau2086. DOI: 10.1126/scitranslmed.aau2086
Taylor MJ, Makunde WH, McGarry HF, Turner JD, Mand S, Hoerauf A. Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial. Lancet. 2005 Jun 18-24;365(9477):2116-21. DOI: 10.1016/S0140-6736(05)66591-9
Thomsen EK, Sanuku N, Baea M, Satofan S, Maki E, Lombore B, Schmidt MS, Siba PM, Weil GJ, Kazura JW, Fleckenstein LL, King CL. Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis. Clin Infect Dis. 2016 Feb;62(3):334-41. DOI: 10.1093/cid/civ882
Townson S, Freeman A, Harris A, Harder A. Activity of the Cyclooctadepsipeptide Emodepside against Onchocerca guttorosa, Onchocerca lienalis and Brugia pahangi. American Society of Tropical Medicine and Hygiene 54th Annual Meeting; Washington, DC, USA; 2005 Dec 11-15.
Townson S, Hutton D, Siemienska J, Hollick L, Scanlon T, Tagboto SK, Taylor MJ. Antibiotics and Wolbachia in filarial nematodes: antifilarial activity of rifampicin, oxytetracycline and chloramphenicol against Onchocerca gutturosa, Onchocerca lienalis and Brugia pahangi. Ann Trop Med Parasitol. 2000 Dec;94(8):801-16. DOI: 10.1080/00034980020027988
Turner HC, Walker M, Attah SK, Opoku NO, Awadzi K, Kuesel AC, Basáñez MG. The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data. Parasit Vectors. 2015 Mar;8:167. DOI: 10.1186/s13071-015-0779-4
Turner JD, Mand S, Debrah AY, Muehlfeld J, Pfarr K, McGarry HF, Adjei O, Taylor MJ, Hoerauf A. A randomized, double-blind clinical trial of a 3-week course of doxycycline plus albendazole and ivermectin for the treatment of Wuchereria bancrofti infection. Clin Infect Dis. 2006 Apr;42(8):1081-9. DOI: 10.1086/501351
Turner JD, Tendongfor N, Esum M, Johnston KL, Langley RS, Ford L, Faragher B, Specht S, Mand S, Hoerauf A, Enyong P, Wanji S, Taylor MJ. Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial. PLoS Negl Trop Dis. 2010;4(4):e660.
Tweats DJ, Johnson GE, Scandale I, Whitwell J, Evans DB. Genotoxicity of flubendazole and its metabolites in vitro and the impact of a new formulation on in vivo aneugenicity. Mutagenesis. 2016 May;31(3):309-21. DOI: 10.1093/mutage/gev070
U.S. Department of Health and Human Services Food and Drug Administration. Determining the Extent of Safety Data Collection Needed in Late-Stage Premarket and Postapproval Clinical Investigations. Silver Spring: FDA; 2016. Available from: https://www.fda.gov/media/82664/download
Velásquez GE, Brooks MB, Coit JM, Pertinez H, Vargas Vásquez D, Sánchez Garavito E, Calderón RI, Jiménez J, Tintaya K, Peloquin CA, Osso E, Tierney DB, Seung KJ, Lecca L, Davies GR, Mitnick CD. Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial. Am J Respir Crit Care Med. 2018 Sep;198(5):657-66. DOI: 10.1164/rccm.201712-2524OC
Volkmann L, Fischer K, Taylor M, Hoerauf A. Antibiotic therapy in murine filariasis (Litomosoides sigmodontis): comparative effects of doxycycline and rifampicin on Wolbachia and filarial viability. Trop Med Int Health. 2003 May;8(5):392-401. DOI: 10.1046/j.1365-3156.2003.01040.x
von Geldern TW, Morton HE, Clark RF, Brown BS, Johnston KL, Ford L, Specht S, Carr RA, Stolarik DF, Ma J, Rieser MJ, Struever D, Frohberger SJ, Koschel M, Ehrens A, Turner JD, Hübner MP, Hoerauf A, Taylor MJ, Ward SA, Marsh K, Kempf DJ. Discovery of ABBV-4083, a novel analog of Tylosin A that has potent anti-Wolbachia and anti-filarial activity. PLoS Negl Trop Dis. 2019 Feb 28;13(2):e0007159. DOI: 10.1371/journal.pntd.0007159
von Saint André A, Blackwell NM, Hall LR, Hoerauf A, Brattig NW, Volkmann L, Taylor MJ, Ford L, Hise AG, Lass JH, Diaconu E, Pearlman E. The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness. Science. 2002 Mar;295(5561):1892-5. DOI: 10.1126/science.1068732
von Samson-Himmelstjerna G, Harder A, Sangster NC, Coles GC. Efficacy of two cyclooctadepsipeptides, PF1022A and emodepside, against anthelmintic-resistant nematodes in sheep and cattle. Parasitology. 2005 Mar;130(Pt 3):343-7. DOI: 10.1017/s0031182004006523
Wanji S, Tendongfor N, Nji T, Esum M, Che JN, Nkwescheu A, Alassa F, Kamnang G, Enyong PA, Taylor MJ, Hoerauf A, Taylor DW. Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon. Parasit Vectors. 2009 Aug;2(1):39. DOI: 10.1186/1756-3305-2-39
Wanji S, Chounna Ndongmo WP, Fombad FF, Kengne-Ouafo JA, Njouendou AJ, Longang Tchounkeu YF, Koudou B, Bockarie M, Fobi G, Roungou JB, Enyong PA. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa. PLoS Negl Trop Dis. 2018 Sep;12(9):e0006750. DOI: 10.1371/journal.pntd.0006750
WHO. Global programme to eliminate lymphatic filariasis: progress report, 2015. Wkly Epidemiol Rec. 2015;39(91):441-560.
WHO. Progress report on the elimination of human onchocerciasis, 2016-2017. Wkly Epidemiol Rec. 2017;92(45):681-700.
WHO. Ending the neglect to attain the Sustainable Development Goals: A road map for neglected tropical diseases 2021-2030. Geneva: World Health Organization; 2020.
WHO. Progress in eliminating onchocerciasis in the WHO Region of the Americas: doxycycline treatment as an end-game strategy. Wkly Epidemiol Rec. 2019;94(37):415-9.
WHO. Elimination of human onchocerciasis: progress report, 2020. Wkly Epidemiol Rec. 2021 Nov 19;96(41):617-23.
WHO. Lymphatic filariasis. [last updated 2022 Mar 16]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/lymphatic-filariasis
WHO. Working to overcome the global impact of neglected tropical diseases - First WHO report on neglected tropical diseases. Geneva: WHO; 2010.
WHO. Progress in eliminating onchocerciasis in the WHO Region of the Americas: doxycycline treatment as an end-game strategy. Wkly Epidemiol Rec. 2019;37(94):415-9.
WHO. Onchocerciasis. [last updated 2022 Jan 11]. Available from: https://www.who.int/news-room/fact-sheets/detail/onchocerciasis
WHO. Global programme to eliminate lymphatic filariasis: progress report, 2020. Wkly Epidemiol Rec. 2021 Oct 15;96(41):497-508.
WHO. Global programme to eliminate lymphatic filariasis: progress report, 2019. Wkly Epidemiol Rec. 2020 Oct;95(43):509-23.
Wu B, Novelli J, Foster J, Vaisvila R, Conway L, Ingram J, Ganatra M, Rao AU, Hamza I, Slatko B. The heme biosynthetic pathway of the obligate Wolbachia endosymbiont of Brugia malayi as a potential anti-filarial drug target. PLoS Negl Trop Dis. 2009 Jul;3(7):e475. DOI: 10.1371/journal.pntd.0000475
Zahner H, Taubert A, Harder A, von Samson-Himmelstjerna G. Filaricidal efficacy of anthelmintically active cyclodepsipeptides. Int J Parasitol. 2001 Nov;31(13):1515-22. DOI: 10.1016/s0020-7519(01)00263-6